138479-78-4

Basic information

• Product Name: 2,3,4,6-TETRA-O-BENZOYL-A-D-GALACTOPYRANOSIDE TRICHLOROACETIMIDATE
• Synonyms: 2,3,4,6-TETRA-O-BENZOYL-A-D-GALACTOPYRANOSIDE TRICHLOROACETIMIDATE;D-Galactose Tetrabenzoate;2,3,4,6-Tetra-O-benzoyl-α-D-galactopyranoside Trichloroacetimidate;(2S,3R)-2-azido-3-O-pivaloyl-1-O-(2',3',4',6'-tetra-O-benzoyl-β-D-galactopyranosy1)-4-pentene
• CAS NO: 138479-78-4
• Molecular Formula: C₃₆H₂₈Cl₃NO₁₀
• Molecular Weight: 740.96722
• Product Categories: 13C & 2H Sugars;Carbohydrates & Derivatives
• Mol File: 138479-78-4.mol

Chemical Properties

• Appearance: /
• Storage Temp.: -20°C Freezer, Under inert atmosphere
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• CAS DataBase Reference: 2,3,4,6-TETRA-O-BENZOYL-A-D-GALACTOPYRANOSIDE TRICHLOROACETIMIDATE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3,4,6-TETRA-O-BENZOYL-A-D-GALACTOPYRANOSIDE TRICHLOROACETIMIDATE(138479-78-4)
• EPA Substance Registry System: 2,3,4,6-TETRA-O-BENZOYL-A-D-GALACTOPYRANOSIDE TRICHLOROACETIMIDATE(138479-78-4)

Safety Data

• Hazardous Substances Data: 138479-78-4(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
2,3,4,6-TETRA-O-BENZOYL-A-D-GALACTOPYRANOSIDE TRICHLOROACETIMIDATE is used as a synthetic intermediate for the creation of complex organic molecules. Its unique structure allows it to be a versatile building block in the synthesis of various compounds, particularly those with biological or pharmaceutical relevance.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,3,4,6-TETRA-O-BENZOYL-A-D-GALACTOPYRANOSIDE TRICHLOROACETIMIDATE is used as a key component in the development of new drugs. Its ability to participate in various chemical reactions makes it a valuable tool for the synthesis of novel drug candidates with potential therapeutic applications.
Used in Chemical Research:
2,3,4,6-TETRA-O-BENZOYL-A-D-GALACTOPYRANOSIDE TRICHLOROACETIMIDATE is also used as a research tool in chemical laboratories. Its unique properties and reactivity make it an interesting subject for studying various chemical reactions and mechanisms, which can lead to a better understanding of organic chemistry and the development of new synthetic methods.
Used in Material Science:
In the field of material science, 2,3,4,6-TETRA-O-BENZOYL-A-D-GALACTOPYRANOSIDE TRICHLOROACETIMIDATE can be used as a component in the development of new materials with specific properties. Its incorporation into polymers or other materials can lead to the creation of materials with unique characteristics, such as improved stability or enhanced biological activity.

Upstream product

• 113544-55-1 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranose 
• 545-06-2 trichloroacetonitrile 
• 2592-58-7 1,2,3,4,6-penta-O-benzoyl-β-D-galactopyranose 
• 7296-64-2 β-D-galactopyranoside 
• 98-88-4 benzoyl chloride 
• 3646-73-9 α-D-galactopyranose 
• 61198-88-7 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl bromide 
• 2592-58-7 1,2,3,4,6-penta-O-benzoyl-α-D-galactopyranoside 
• 2592-58-7 1,2,3,4,6-Penta-O-benzoyl-α-D-galactopyranose 
• 627466-84-6 2,3,4,6-tetra-O-benzoyl-D-galactose 

Downstream Products

• 138479-80-8 Benzyl 2,3-O-isopropylidene-4-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-β-D-xylopyranoside 
• 70751-57-4 C₄₆H₄₆O₁₅ 
• 753500-17-3 4-methoxyphenyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1->6)-3-O-allyl-2,4-di-O-benzoyl-β-D-galactopyranoside 
• 1232690-28-6 C₄₄H₄₃N₃O₁₂ 
• 1335110-73-0 phenyl (2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-(1->4)-6-O-(tert-butyldiphenylsilyl)-2-deoxy-2-(2,2,2-trichloroethoxy)carbonylamino-1-thio-β-D-glucopyranoside 
• 1355331-87-1 5-(N-benzyloxycarbonyl)-aminopentyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside 
• 1574563-68-0 C₃₅H₃₀O₉Se 
• 334980-58-4 allyl (2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-(1→3)-2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-galactopyranoside 

Relevant articles and documents

VACCINE COMPOSITIONS AND ANTIBODIES FOR LYME DISEASE

The present invention relates to vaccine compositions comprising lipid antigens, antibodies targeting lipid antigens, pharmaceutical compositions comprising such and their use in diagnosing, monitoring, treating, and preventing infectious disease, such as Lyme disease. In one aspect, administered is a therapeutically effective amount of a vaccine composition comprising a lipid antigen, an antibody or fragment thereof binding a lipid antigen, and/or a pharmaceutical composition comprising an antibody or fragment thereof binding a lipid antigen. Other aspects are described.

Experimental and theoretical study of the O3/O4 regioselectivity of glycosylation reactions of glucopyranosyl acceptors

The knowledge of the regioselectivity between different hydroxyl groups of glycosyl acceptors is valuable in planning simple strategies for the synthesis of oligosaccharides, minimizing the use of protecting groups. With the aim of obtaining deeper knowle

The dehydroepiandrosterone and dehydroepiandrosterone alkone glycosylation derivative and its preparation method and application

The invention discloses epiandrosterone glycosylation derivatives and dehydrogenated epiandrosterone glycosylation derivatives, and a preparation method thereof. The preparation method comprises the following steps: respectively carrying out coupling reac

3 - monosaccharide acid oxygen glucoside oleanolic alkane type and wusu alkane triterpene saponin derivative and its preparation method and application

The invention discloses a 3-monouronic acid o-glycoside oleanane type and ursane type triterpenoid saponin derivative. The derivative has a structural formula as shown in the specification, wherein R4 is one of H atom, alkyl containing 1-10 carbons, alkyl

Mitochondrial affinity of guanidine-rich molecular transporters built on monosaccharide scaffolds: Stereochemistry and lipophilicity

We synthesized eight G8 molecular transporters (MTs) based on 4 different monosaccharide scaffolds, and studied their biological properties with a special focus on possible mitochondrial targeting and tissue selectivity. The mitochondrial affinity of these MTs was found to be clearly related to the scaffold stereochemistry and also tenuously with the lipophilicity. It may be suggested that in the practical delivery strategy of drugs for the brain and mitochondrial diseases the BBB permeability and mitochondrial affinity should be considered as key parameters, and that an enhanced mitochondrial affinity appears possible by further research on the structure-property relationship of guanidine-rich molecular transporters.

Synthesis and properties of a photoactivatable analogue of psychosine (β-galactosylsphingosine)

(Chemical Equation Presented) Photoaffinity probes: The first synthesis of a photoaffinity probe of psychosine (blue) is reported, where benzophenone (red) is tethered as a crosslinking moiety. This photo-psychosine probe (shown) displayed a similar potency as psychosine in stimulating Ca2+ flux in U937 cells, suggesting that it may be useful for labeling and identifying the still unidentified psychosine receptor(s) by mass spectrometry.

SnCl4- and TiCl4-catalyzed anomerization of acylated O - And S -glycosides: Analysis of factors that lead to higher α: β d reaction rates

The quantification of factors that influence both rates and stereoselectivity of anomerization reactions catalyzed by SnCl4 and TiCl4 and how this has informed the synthesis of α-O- and α-S-glycolipids is discussed. The SnCl4-catalyzed anomerization reactions of β-S- and β-O-glycosides of 18 substrates followed first order equilibrium kinetics and kf + kr values were obtained, where kf is the rate constant for the forward reaction (β → α) and kr is the rate constant for the reverse reaction (α → β). Comparison of the kf + k r values showed that reactions of glucuronic acid or galacturonic acid derivatives were ～10 to 3000 times faster than those of related glucoside and galactopyranoside counterparts and α:β ratios were generally also higher. Stereoelectronic effects contributed from galacto-configured compounds were up to 2-fold faster than those of corresponding glucosides. The introduction of groups, including protecting groups, which are increasingly electron releasing generally led to rate enhancements. The anomerization of S-glycosides was consistently faster than that of corresponding O-glycosides. Reactions were generally faster for reactions with TiCl4 than those with SnCl4. Anomeric ratios depended on the Lewis acid, the number equivalents of the Lewis acid, temperature, and substrate. Very high ratios of α-products for both O- and S-glucuronides were observed for reactions promoted by TiCl4; for these substrates TiCl4 was superior to SnCl4. Anomeric ratios from anomerization of S-glucosides were higher with SnCl4 than with TiCl4. The dependence of equilibrium ratio on Lewis acid and the number of equivalents of Lewis acid indicated that the equilibrium ratio is determined by a complex of the saccharide residue bound to the Lewis acid and not the free glycoside. The high α:β ratios observed for anomerization of both O- and S-glycuronic acids can be explained by coordination of the C-1 heteroatom and C-6 carbonyl group of the product to the Lewis acid, which would enhance the anomeric effect by increasing the electron-withdrawing ability of the anomeric substituent and lead to an increase in the proportion of the α-anomer. Such an observation would argue against the existence of a reverse anomeric effect. Support for a chelation-induced endocyclic cleavage mechanism for the anomerization is provided by the trapping of a key intermediate. The data herein will help predict the tendency of β-glycosides to undergo anomerization; this includes cases where 1,2-trans glycosides are initial products of glycosidation reactions catalyzed by TiCl4 or SnCl4.

Synthesis and cytotoxicity evaluation of natural α-bisabolol β-d-fucopyranoside and analogues

α-Bisabolol β-d-fucopyranoside, a cytotoxic naturally occurring compound, was efficiently synthesized along with five other α-bisabolol glycosides (β-d-glucoside, β-d-galactoside, α-d-mannoside, β-d-xyloside and α-l-rhamnoside). Glycosidation of α-bisabol

Syntheses and interfacial behaviour of neoglycolipid analogues of glycosyl ceramides

Four glycosyl ceramides analogues having D-galactose or 2-acetamido-2-deoxy-D-glucose moieties linked to enantiomeric lipids have been synthesised to study their interfacial behaviour at the air | water interface. The lipid chains were prepared in two steps by opening 1,2-epoxyhexadecane using Jacobsen kinetic hydrolytic resolution (KHR) followed by an azidosilylation reaction of the diol so obtained. Glycosylation reactions were realised either with 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl trichloroacetimidate or 1,3,4,6-tetra-O-acetyl-2-allyloxycarbonylamino-2-deoxy-β-D-glucopyranose as donors and (2R)- or (2S)-2-azidohexadecanol derivatives as acceptors. Transformation of the azido glycosides into N-acylated products was done by a modified Staudinger reaction in the presence of fatty acyl chlorides. The four neoglycolipids are able to form a condensed monolayer at the air | water interface; their π-A isotherm diagrams are similar to that described for the natural glycosyl ceramides. The detailed analysis of the isotherms, taking into account the chirality of the lipid chains, allowed to determine the contribution of the different parts of the molecule under the monolayer packing.

A simple access to 3,6-branched oligosaccharides: Synthesis of a glycopeptide derivative that relates to Lycium barbarum L.

An efficient method is described for the synthesis of galactopyranosyl-containing 3,6-branched oligosaccharides using isopropyl thiogalactopyranoside as starting material. This method is successfully applied to the preparation of a glycopeptide derivative that relates to Lycium barbarum L. The potential application of isopropyl thioglycoside in glycosylation is also investigated.